SRTS stock news · Sensus Healthcare, Inc.
Get alerts for SRTS
Follow Sensus Healthcare, Inc. (SRTS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SRTSSensus Healthcare's sales dropped last quarter, and analysts kept their 'buy' rating but lowered the price target.
Bad for SRTSSensus Healthcare's second-quarter sales fell, and it posted an adjusted loss. Approved delayed units may lift next quarter, but the results and lower analyst target point to a weaker outlook.
Sensus Healthcare Q2 2026 Earnings Call Complete Transcript Released.
Good for SRTSSensus Healthcare's Q2 2026 earnings call disclosed a substantial drop in revenue compared to the previous year, primarily due to fewer units sold and delayed revenue recognition. Despite these challenges, the company is optimistic about future growth driven by new technology adoption and international expansion, particularly in regions with high skin cancer rates.
Sensus Healthcare, Inc. discloses operational outcomes and financial status (SRTS).
NeutralSensus Healthcare, Inc. has filed a Form 8-K detailing its results of operations and financial condition, which could lead to immediate market reactions as investors assess the implications of the new information.